Гемостаз и эстеразная активность крови крыс при интоксикации фосфорорганическими отравляющими веществами
Диссертация
Через 3 часа после острого отравления ингибирование эритроцитарной АХЭ и сывороточной БХЭ вызывают повышение уровня ацетилхолина в кровеносном русле (на фоне выраженных холинергических симптомов). Действие АХ на эндотелий сопряжено со стимуляцией М-рецепторов, мобилизацией внутриклеточного кальция, генерацией окиси азота. Чрезмерная активация обусловливает повреждение эндотелия, нарушение… Читать ещё >
Содержание
- ПЕРЕЧЕНЬ УСЛОВНЫХ ОБОЗНАЧЕНИЙ
- ВВЕДЕНИЕ '
- Глава 1. Токсикология фосфорорганических соединений и система гемостаза млекопитающих (Обзор литературы) 11 1.1. — Фосфорорганические соединения (ФОС) и механизм их токсического действия
- 1. 2. — Структурно-функциональные аспекты гемостаза
- Структура и функции тромбоцитов
- Структура и функции эритроцитов
- Гуморальный (плазменный) гемостаз
- 1. 3. — Гемостаз и возможные механизмы развития патогенеза при интоксикации ФОС
- 1. 4. — Обзор литературы: Резюме
- Глава 2. МАТЕРИАЛЫ И МЕТОДЫ ИССЛЕДОВАНИЯ
- Глава 3. РЕЗУЛЬТАТЫ ИССЛЕДОВАНИЯ И ИХ ОБСУЖДЕНИЕ
- 3. 1. — Динамика относительного изменения массы животных после острого отравления
- 3. 2. — Биохимические показатели в динамике после острого отравления крыс зоманом и RVX
- 3. 3. — Исследование эстеразной активности крови
- 3. 4. — Изменение параметров агрегации тромбоцитов после острого отравления ФОВ
- 3. 5. — Исследование функционального статуса эритроцитов при интоксикации ФОВ
- 3. 6. — Изменение показателей гуморального гемостаза после острого отравления зоманом и RVX
- 3. 7. — Исследование активности ADAMTS13 в культуре эндотелиальных клеток
- 3. 8. — Исследование сывороток крови крыс после отравления зоманом и RVX методом масс-спектрометрии с ионизацией лазерной десорбцией в присутствии матрицы (MALDI)
Список литературы
- Авдонин П.В., Ткачук В. А. Рецепторы и внутриклеточный кальций. // М.: Наука, 1994. -288с.
- Балуда В.П., Балуда М. В., Деянов И. И., Тлепшуков И. К. Физиология системы гемостаза. // Москва, 1995.
- Баркаган З.С. Геморрагические заболевания и синдромы. // М.: Медицина, 1988. -528с.
- Баркаган З.С., Бишевский К. М. Физиологические антикоагулянты. Современное представление о составе, функции и клиническое значение // Лабораторное дело. -1978. — № 10. С.579−586.
- Беленький М.Л. Элементы количественной оценки армакологического эффекта. // Рига, 1959.- 114с.
- Вестрайт М., Вермилен Дж. Тромбозы. // М.: Медицина, 1986.
- Гаврилов O.K., Козинец Г. Н., Черняк Н. Б. Клетки костного мозга и периферической крови. // М.: Медицина, 1985. 288с.
- Дарбре А. Практическая химия белка. // М.: Мир, 1985. 456 с.
- П.Деркачев Э. Ф., Миндукшев И. В., Кривченко А. И., Крашенниников А. А. Способ исследования активации и агрегации тромбоцитов. // Патент RU 2 108 579 С1 6 G01 N 33/49. 1998. Б.И. № 10 (II). С. 98.
- Долгов В.В., Свирин П. В. Лабораторная диагностика нарушений гемостаза. // М. -Тверь: ООО «Издательство „Триада“, 2005. 227с.
- Зубаиров Д.М. Молекулярные основы свертывания крови и тромбообразования. // Казань: Из-во „ФЭН“, 2000.
- Иванов Е.П. Руководство по гемостазиологии. // Минск, 1991.
- Козинец Г. И., Макарова В. А. (ред.). Исследование системы крови в клинической практике. // М., 1998. 480с.
- Костюк П.Г. Кальций и клеточная возбудимость. // М.: Наука, 1986. — 255с.
- Ложкина А.Н. //Автореферат дис.. канд.биол.наук. Иркутск, 1988.
- Мазур Э.М. Патофизиология крови. // М. СПб.: БИНОМ — Невский Диалект, 2000. -С. 54−156
- Маршалл Дж.В. Клиническая биохимия. // М.-СПб.: БИНОМ Невский Диалект, 2000. -368с.
- Музыкантов В.Р., Сахаров Д. В., Домогатский С. П., Гончаров Н. В., Данилов С. М., Смирнов В. Н. Защита эндотелиальных клеток от цитотоксического действия перекиси водорода посредством иммуноэритроцитов. // Доклады АН СССР 1986. — Т.288 -№ 3 — С.748−750.
- Мусийчук Ю.И., Янно Л. В. О состоянии исследования отдаленных последствий действия химических веществ у людей. // Гигиена труда и профессиональные заболевания. 1988. — № 9. — С. 4−7.
- Осадчая Л.М. Свободные аминокислоты нервной системы. // В кн. „Биохимия мозга“. (Ред. Ашмарин И. П. и др.) Изд. СпбГУ. — 1999. — С.29−56.
- Папаян Л.П. Новое представление о процессе свертывания крови // Папаян Л. П. (ред) Система гемостаза. — СПб.-2003.
- Плужников Н.Н., С.В. Чепур, А. В. Лешневский и др. Профилактика отдаленных нейропатий при отравлениях ФОС. // Медико-гигиенические аспекты обеспечения работ с особо опасными химическими веществами. СПб, 2002. — С.407−408.
- Ройтберг Г. Е., Струтынский А. В. Лабораторная и инструментальная диагностика заболеваний внутренних органов Электрон, ресурс. 2003. — Режим доступа: http://rnedbook.medicina.ru/index.php7id level=337
- Самаль А.Б., Черенкевич С. Н., Хмара Н. Ф. Агрегация тромбоцитов: методы изучения и механизмы. // Мн.: Университетское изд., 1990. 104с.
- Соколовская Л.Г., Сиголаева Л. В., Еременко А. В. и др. Семейство биосенсорных анализаторов для оценки „эстеразного статуса“ организма. // Химическая и биологическая безопасность. 2004. — № 1−2. — С.21−33.
- Теппермен Дж., Теппермен X. Физиология обмена веществ и эндокринной системы. Вводный курс. // М.: Мир, 1989. 656с.
- Терсков Г. В., Гительзон И. И. Метод химических (кислотных) эритрограмм. // Биофизика. 1957. — Т.2. — № 2. — С.259−263.
- Уайт А., Хендлер Ф., Смит Э., Хилл Р., Леман И. Основы биохимии: В 3-х томах. // Т.1., М.: Мир, 1981.-534с.
- Фултон А. Цитоскелет. Архитектура и хореография клетки. // М.: Мир, 1987. С. 120.
- Хашен Р., Шейх Д. Очерки по патологической биохимии. // М.: Медицина, 1981. -253с.
- Хримель X., Брок И. Основы иммунологии. // М., 1986. — 254с.
- Хухо Ф. Нейрохимия: Основы и принципы. // М.: Мир, 1990. 384с.
- Чепур С.В., В.Б. Василюк, Л.В. Павлова. Применение карбаматов для экстренной профилактики отсроченных нейропатий при отравлении органофосфатами. // Актуальные вопросы военно-полевой терапии: мат. II всеарм. конф. — СПб., 1999. -С.285−286
- Чепур С.В., Юдин М. А., Быков В. Н. Изменение структуры и функциональных свойств эндотелия сосудов гемомикроциркуляторного русла при токсическом холинопозитивном синдроме. // Морфология. 2006. — Т.129. — № 2. — С. 106.
- Шиффман Ф.Д. Патофизиология крови. // М.-Спб.: БИНОМ — Невский Диалект, 2000. С.149−283.
- Abou-Donia М.В. Organophosphorus ester-induced delayed neurotoxicity. // Annu. Rev. Pharmacol. Toxicol. 1981. -V.21. — P.511−548.
- Ahmad S.S., London F.S., Walsh P.N. The assembly of the factor X-activating complex on activated human platelets. // J. Thromb. Haemost. -2003. V.l. — P.48−59.
- Anderson R.J., Dunham C.B. Electrophysiologic changes in peripheral nerve following repeated exposure to organophosphorus agents. // Arch. Toxicol. 1985. — V.58. — P.97−101.
- Ashmun R.A., Look A.T. Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells. // Blood. 1990. — V.75. — № 2. -P.462−469.
- Auman J.T., Seidler F.J., Slotkin T.A. Neonatal chlorpyrifos exposure targets multiple proteins governing the hepatic adenylyl cyclase signaling cascade: implications for neurotoxicity. // Dev. Brain Res. 2000. — V. 121. — P. 19−27.
- Authi K.S. Ca2+ homeostasis and intracellular pools in human platelets. // Adv. Exp. Med. Biol. 1993. — V.344. — P.83−104.
- Barbosa M., Rios O., Velasquez M., Villalobos J., Ehrmanns J. Acetylcholinesterase and butyrylcholinesterase histochemical activities and tumor cell growth in several brain tumors. // Surg. Neurol. 2001. — V.55. — № 2. — P.106−112.
- Bartels C.F., Zelinski Т., Lockridge O. Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism. // Am. J. Hum. Genet. 1993,-V.52.-№ 5.-P.928−936.
- Bauvois В., Dauzonne D. Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects. // Med. Res. Rev. 2006. — V.26. — № 1. -P.88−130.
- Berk M., Plein H., Csizmadia T. Supersensitive platelet glutamate receptors as a possible peripheral marker in schizophrenia. // Int. Clin. Psychopharmacol. — 1999. — V.14. — № 2. — P. l 19−122.
- Berk M., Plein H., Ferreira D. Platelet glutamate receptor supersensitivity in major depressive disorder. // Clin. Neuropharmacol. 2001. — V.24. -№ 3. — P. l29−132.
- Bertoncin D., Russolo A., Caroldi S., Lotti M. Neuropathy target esterase in human lymphocytes. // Arch. Environ. Health. 1985. — V.40. — P. l39−144.
- Bessis. M., Weed. R.I., Leblond P. F. (Eds.) Red Cell Shape: Physiology, Pathology, Ultrastructure. // Springer Verlag, Heidelberg, 1973. P. 1−23.
- Bhagwat S.V., Lahdenranta J., Giordano R., Arap W., Pasqualini R, Shapiro L.H. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. // Blood. 2001. — V.97. — № 3. — P.652−659.
- Bhagwat S.V., Petrovic N., Okamoto Y., Shapiro L.H. The angiogenic regulator CD13/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis. // Blood. 2003. — V. 101. — № 5. — P. 1818−1826.
- Black R.M., Harrison J.M., Read R.W. The interaction of sarin and soman with plasma proteins: the identification of a novel phosphonylation site. // Arch. Toxicol. 1999. — V.73. -№ 2. -P. 123−126.
- Blann A.D. von Willebrand and atherosclerosis. // J. Intern. Med. 1995. — V.237. — P.432−433.
- Blomback B. Fibrinogen to fibrin transformation. // In Blood Clotting Enzymology. (Ed. Seegers W.H.). Academic Press, Inc., New York, 1967. P. 143−215.
- Boas F.E., Forman L., Beutler E. Phosphatidylserine exposureand red cell viability in red cell aging and in hemolyticanemia. // Proc. Natl. Acad. Sci. USA. 1998. — V.95. — P.3077−3081.
- Bratosin D., Mazurier J., Tissier J.P., Estaquier J., Huart J.J., Ameisen J.C., Aminoff D., Montreuil J. Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. // Biochimie. 1998. — Y.80. — № 2. — P. 173−195.
- Brenner В., Zwang E., Bronshtein M., Seligsohn U. von Willebrand factor multimer patterns in pregnancy-induced hypertension. // Thromb. Haemost. 1989. -V.62. -P.715−717.
- Browne R.W., Koury S.T., Marion S., Wilding G., Muti P., Trevisan M. Accuracy and Biological Variation of Human Serum Paraoxonase 1 Activity and Polymorphism (Q192R) by Kinetic Enzyme Assay // Clin Chem. 2007. — V.53 — № 2. — P.310−317.
- Buonassisi V., Venter J.C. Hormone and neurotransmitter receptors in an established vascular endothelial cell line. // Proc. Natl. Acad. Sci. 1976. — V.73. -№ 5. -P.1612−1616
- Carvalho F.A., Gra? a L.M., Martins-Silva J., Saldanha C. Biochemical characterization of human umbilical vein endothelial cell membrane bound acetylcholinesterase. // FEBS J. -2005. V.272. — № 21. — P.5584−5594.
- Casida J.E., Quistad G.B. Serine hydrolase targets of organophosphorous toxicants. // Chem. Biol. Interact. 2005. — V. 157−158. — P.277−283.
- Catalan R.E., Hernandez F. Temperature effects on cholinesterases from rat brain capillaries. // Biosci. Rep. 1986. — V.6. — № 6. — P.573−577.1.l
- Chemnitius J.M., Zech R. Inhibition of brain carboxylesterases by neurotoxic and non-neurotoxic organophosphorous compounds. // Molec. Pharmacol. 1983. — V.23. — P.717−723.
- Chiaroni J. Numeric terminology of erythrocyte blood group antigens. Article in French. // Transfus. Clin. Biol. 1998. — V. 5. — № 5. — P.366−371.
- Choudhary S., Gill K.D. Protective effect of nimodipine on dichlorvos-induced delayed neurotoxicity in rat brain (l). // Biochem. Pharmacol. 2001. — V.62. — № 9. — P. 1265−1272.
- Churchill L., Bausback H.H., Gerritsen M.E., Ward P.E. Metabolism of opioid peptides by cerebral microvascular aminopeptidase M. // Biochim. Biophys. Acta. 1987. — V.923. -№ 1. — P.35−41.
- Cines D.B., Pollak E.S., Buck C.A., Loscalzo J., Zimmerman G.A. et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. // Blood. 1998. — V.91.I1. P.3527−3561.
- Clark M.R. Senescence of red blood cells: progress and problems. // Physiol. Rev. 1988. — V.68. — P.503−554.
- Cline J.K., Johnson R.B., Johnson W.H. Cholinesterase content of erythrocytes in various anemic states- preliminary report. // South. Med. J. 1948. — V.41. — № 4. — P.374−376.
- Costa L.G. Biomarker research in neurotoxicology: The role of mechanistic studies to bridge the gap between the laboratory and epidemiological investigations // Envor. Health Persp. -1996.-V. 104.- Suppl.l.-P.55−67.
- Costa L.G. Basic toxicology of pesticides. // Occup. Med. State. Art. Rev. 1997. — V.12. -P.251−268.
- Costa L.G., Cole T.B., Vitalone A., Furlong C.E. Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity. // Clin. Chim. Acta. 2005. — V.352. — № 1−2. — P.37−47.
- Crott J.W., Fenech M. Effect of vitamin С supplementation on chromosome damage, apoptosis and necrosis ex vivo. // Carcinogenesis. 1999. — V.20. -№ 6. — P. 1035−1041.
- Daleke D.L., Huestis W.H. Erythrocyte morphology reflects the transbilayer distribution of incorporatedphospholipids. // J. Cell. Biol. 1989. — V. 108. — № 4. — P. 1375−1385.
- Daniel J.L., Adelstein R.S. Isolation and properties of platelet myosin light chain kinase. // Biochemistry. 1976. — V.15. — P.2370−2377.
- Davie E.W., Ratnoff O.D. Waterfall sequence for intrinsic blood clotting. // Science. 1964. — V.145. -P.1310−1312.
- Davies D.R. Neurotoxicity of organophosphorus compounds. // In: Cholinesterase and Anticholinesterase Agent. Berlin: Springer, 1963. — P.860−882.
- De Groot D.M., Bierman E.P., Van Huygevoort A.N. Involvement of NMDA-receptors in soman-induced neuropathology. // Proc. Med. Def. Biosci. Rev. 1993. — V.2. — P. 447−455.
- Desi I., Nagymajtenyi L. Electrophysiological biomarkers of an organophosphorous pesticide, dichlorvos. // Toxicol. Lett. 1999. — V.107. -№ 1−3. — P.55−64.
- Drachman D. Do we have brain to spare? // Neurology. 2005. — V.64. — № 12. — P.2004−2005.
- Eber S., Lux S.E. Hereditary spherocytosis-defects in proteins that connect the membrane skeleton to the lipid bilayer. // Semin. Hematol. 2004. — V.41. — № 2. — P. 118−141.
- Ellman G., Courtney D., Andres V. A new and rapid colorimetric determination of acetylcholinesterase activity. // Biochem. Pharmacol. 1961. — V.7 — P.88−95.
- Essler M., Amano M., Kruse H.-J., Kaibuchi K., Weber P.C. Aepfelbacher M. Thrombin Inactivates Myosin Light Chain Phosphatase via Rho and Its Target Rho Kinase in Human Endothelial Cells. // J. Biol. Chem. 1998. — V.273. — P.21 867−21 874.
- Farkas E., de Jong G.I., de Vos R.A.I., Jansen Steur E.N.H., Luiten P.G.M. Pathological features of cerebral cortical capillaries are doubled in Alzheimer’s disease and Parkinson’s disease. // Acta Neuropathol. (Berl). 2000. — V.100. — № 4. — P.395−402.
- Favaloro E.J., Browning Т., Facey D. CD13 (GP150- aminopeptidase-N): predominant functional activity in blood is localized to plasma and is not cell-surface associated. // Exp. Hematol. 1993. — V.21. — № 13. — P.1695−1701.
- Fenech M. The advantages and disadvantages of the cytokinesis-block micronucleus method. // Mutat. Res. 1997. — V.392. -№ 1−2. — P. l 1−18.
- Ferrell J.E., Lee K.J., Huestis W.H. Membrane bilayer balance and erythrocyte shape: a quantitative assessment. // Biochemistry. 1985. — V.24. — № 12. — P.2849−2857.113
- Finney D.J. Probit analysis. // Cambridge: University Press, 1980. 333p.
- Franconi F., Miceli M., De Montis M.G., Crisafi E.L., Bennardini F., Tagliamonte A. NMDA receptors play an anti-aggregating role in human platelets. // Thromb. Haemost. — 1996. V.76. — № 1. — P.84−87.
- Franconi F., Miceli M., Alberti L., Seghieri G., De Montis M.G., Tagliamonte A. Further insights into the anti-aggregating activity of NMDA in human platelets. // Br. J. Pharmacol. 1998. — V. 124. -№ 1. — P.35−40.
- Frojmovic M.M., Milton J.G. Human platelet size, shape, and related functions in health and disease. // Physiolog. Rev. 1982. — V.62. — № 1. — P. 185 — 261.
- Furchgott R. F, Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. //Nature. 1980. — V. 288. — № 5789. — P.373−376.
- Furie В., Furie B. Thrombus formation in vivo. // J. Clin. Invest. 2005. — V. l 15. -№ 12. — P.3355−3362.
- Galdal K.S. Thromboplastin Synthesis in Endothelial Cells. // Pathophysiol. Haemost. Thromb. 1984. — V.14. -P.378−385.
- Garcia C.A., Ruiz R.S. Diabetes and the eye. // Clin. Symp. 1984. — V.36. — № 4. -P.2−32.
- Gedde M.M., Davis D.K., Huestis W.H. Cytoplasmic pH and human erythrocyte shape. // Biophys. J. 1997. — V.72. — № 3. — P.1234−1246.
- Geer C.B., Rus I.A., Lord S.T., Schoenfisch M.H. Surface-dependent fibrinopeptide A accessibility to thrombin. // Acta Biomater. 2007. — V.3. — № 5. — P.663−668.
- Giacobini E. Cholinesterases: new roles in brain function and in Alzheimer’s disease. // Neurochem. Res. 2003. — V.28. — № 3−4. — P.515−522.
- Giangrande P.L. Six characters in search of an author: the history of the nomenclature ofcoagulation factors. // Br. J. Haematol. 2003. — V.121. — № 5. — P.703−712.
- Glynn P. Neural development and neurodegeneration: two faces of neuropathy target esterase. // Prog. Neurobiol. 2000. — V.61. — № 1. — P.61−74.
- Goncharov N.V., Radilov A.S., Mindukshev I.V., Yermolayeva Ye.Ye., Kuznetsov S.V., Glashkina L.M., Dobrylko I.A., Kuznetsov A.V. Effects of RVX Low Dose Chronic114
- Exposure on Rat Platelet Aggregation and Physiology of Nerve Fibres. // In: Economy, Logistic, and Ecology in Armed Forces III. International Scientific Conference. Brno, 2003. — P.63−70.
- Gupta M., Bagchi G., Bandyopadhyay S., Sasmal D., Chatterjee Т., Dey S.N. Hematological changes produced in mice by Nuvacron or Furadan. // Toxicology. 1982. -V.25. — № 2−3. — P.255−260.
- Gurwitz D., Cunningham D. D. Thrombin modulates and reverses neuroblastoma neurite outgrowth. // Proc. Natl. Acad. Sci. USA. 1988. — V.85. — P.3440−3444.
- Hallak M., Giacobini E. Relation of brain regional physostigmine concentration to cholinesterase activity and acetylcholine and choline levels in rat. // Neurochem. Res. -1986. V. l 1. — № 7. — P. 1037−1048.
- Harpel P.C., Mosesson M.M. Degradation of human fibrinogen by plasma a2-macroglobulin-enzyme complexes. // J. Clin. Invest. 1973. — V.52. — P.2175−2184.
- Heemskerk J.W.M., Bevers E.M., Lindhout T. Platelet activation and blood coagulation. // Thromb. Haemost. 2002. — V.88. — P. 186−193.
- Hjort P.F., Hasselback R. A critical review of the evidence for a continous hemostasis in vivo. //Thromb. Diath. Haemorrh.- 1961,-V.15.-№ 6.-P.580−612.
- Hoffman M., Monroe D.M. A cell-based model of hemostasis. // Thromb. Haemost. -2001.- V.85. -P.958−965.
- Hoffman M., Monroe D.M., Roberts H.R. Cellular interactions in hemostasis. // Haemostasis. 1996. — V.26. — P.12−16.
- Hsu S.H., Tsou T.C., Chiu S.J., Chao J.I. Inhibition of aIpha7-nicotinic acetylcholine receptor expression by arsenite in the vascular endothelial cells. // Toxicol. Lett. 2005. -V.159. — № 1. — P.47−59.
- Hughes R.A., Gabriel C.M., Gregson N.A., Smith K.J. Treatment of inflammatory neuropathy. //Mult. Scler. 1997. — V.3. -№ 2. -P.88−92.115
- Iwanaga S., Wallen P., Grondahl N.J., Henschen A., Blomback В. On the primary structure of human fibrinogen. Isolation and characterization of Nterminal fragments from plasmic digests. // Eur. J. Biochem. 1969. — V.8. — P. 189−199.
- Jaiswal N., Lambrecht G., Mutschler E. et al. Pharmacological characterization of the vascular muscarinic receptors mediating relaxation and contraction in rabbit aorta. // J. Pharmacol. Exp. Ther. 1991. — V.258. — № 3. — P.842−850.
- Jamal G.A. Neurological syndromes of organophosphorus compounds. // Adverse Drug. React. Toxicol. Rev. 1997. — V.16. -№ 3. — P.133−170.
- Jamieson G.A., Agrawal A.K., Greco N.J., Tenner Т.Е. Jr., Jones G.D. et al. Phencyclidine binds to blood platelets with high affinity and specifically inhibits their activation by adrenaline. // Biochem. J. 1992. — V.285 — № 1. — P.35−39.
- Jewell W.T., Miller M.G. Identification of a carboxylesterase as the major protein bound by molinate. // Toxicol. Appl. Pharmacol. 1998. -V.149. — № 2. — P.226−234.
- John S., Kale M., Rathore N., Bhatnagar D. Protective effect of vitamin E in dimethoate and malathion induced oxidative stress in rat erythrocytes. // J. Nutr. Biochem. — 2001. V.12. — № 9. — P.500−504.
- Johnson M.K. A phosphorylation site in brain and the delayed neurotoxic effect of some organophosphorus compounds. // Biochem. J. 1969a. -V.l 11. — P.487−495.
- Johnson M.K. The delayed neurotoxic effect of some organophosphorus compounds. Identification of the phosphorylation site as an esterase. // Biochem. J. 1969b. — V. l 14 -P.711−717.
- Johnson M.K. The primary biochemical lesion leading to the delayed neurotoxic effects of some organophosphorus esters. // J. Neurochem. 1974. — V.23. — № 4. — P.785−789.
- Johnson M.K. Improved assay of neurotoxic esterase for screening organophosphates for delayed neurotoxicity potential. //Arch. Toxicol. 1977. -V.37 — P. l 13−115.
- Johnson M.K. Irreversible phosphorylation of brain neurotoxic esterase. The primary event leading to the delayed neuropathy caused by some organophosphorus esters. // Monogr. Neural. Sci. 1980.-V.7.-P.99−105.
- Johnson M.K. The target for initiation of delayed neuroxicity by organophosphorus esters: biochemical studies and toxicological applications. // In: Reviews in Biochemical116
- Toxicology. (Ed. by E. Hodgson, J.R. Bend, R.M. Philpot), Elsevier, Amsterdam, New York, 1982-P.141—212.
- Joiner C.H., Franco R.S., Jiang M., Franco M.S., Barker J.E., Lux S.E. Increased cation permeability in mutant mouse red blood cells with defective membrane skeletons. // Blood. 1995. — V.86. -№ 11.- P.4307−4314.
- Kanda Т., Iwasaki Т., Mizusawa H. Glycosphingolipid antibodies and blood-nerve barrier in autoimmune demyelinative neuropathy. // Neurology. 2000. — V.54. — № 7. -P. 1459−1464.
- Kawashima K., Fujii T. Basic and clinical aspects of non-neuronal acetylcholine: overview of non-neuronal cholinergic systems and their biological significance. // J. Pharmacol. Sci. 2008. — V. 106. — P. 167−173.
- Kikuchi H., Y. Suzuki and Y.Hashimoto. Increase of beta-glucuronidase activity in the serum of rats administered organophosphate and carbamate insecticides. // J. Toxicol. Sci. 1981.- V.6.-P.27−35.
- Kirkpatrick C.J., Bittinger F., Unger R.E. The non-neuronal cholinergic system in the endothelium: evidence and possible pathobiological significance. // Jpn. J. Pharmacol. -2001. V.85. — № 1. — P.24−28.
- Kirkpatrick C.J., Bittinger F., Nozadze K., Wessler I. Expression and function of the nonneuronal cholinergic system in endothelial cells. // Life Sci. 2003. — V.72. — №.18−19. -P.2111−2116.
- Klaidman L.K., Adams J.D. Jr., Cross R., Pazdernik T.L., Samson F. Alterations in brain glutathione homeostasis induced by the nerve gas soman. // Neurotox. Res. — 2003. — V.5. — № 3. P. 177−182.
- Krishnasamy S., Gross N.J., Teng A.L., Schultz R.M., Dhand R. Lung „surfactant convertase“ is a member of the carboxylesterase family. // Biochem. Biophys. Res. Commun. 1997. -V.235. — P.180−184.
- Lacy F., Gough D.A., Schmid-Schonbein G.W. Role of xanthine oxidase in hydrogen peroxide production. // Free Radic. Biol. Med. 1998. — V.25. — № 6. — P.720−727.
- Lalu K., Lampelo S., Vanha-Perttula T. Characterization of three aminopeptidases purified from maternal serum. // Biochim. Biophys. Acta. 1986. — V.873. — № 2. — P.190−197.
- Lane R.M., Potkin S.G., Enz A. Targeting acetylcholinesterase and butyrylcholinesterase in dementia. // Int. J. Neuropsychopharmacol. — 2006. V.9. — № 1. -P.101−124.
- Lang F., Lang K., Lang P., Huber S., Wieder T. Osmotic shock-induced suicidal death of erythrocytes. // Acta. Physiol. (Oxf). 2006. — V.187. — № 1−2. — P. 191−198.
- Lang K., Duranton C., Poehlmann H., Myssina S., Bauer C., Lang F., Wieder T. and Huber S. Cation channels trigger apoptotic death of erythrocytes. // Cell. Death. Differ. -2003. — № 10. -P.249−256.
- Lang K., Myssina S., Brand V., Sandu C., Lang P., Berchtold S., Huber S., Lang F. and Wieder T. Involvement of ceramide in hyperosmotic shockinduced death of erythrocytes. // Cell. Death. Differ. 2004. — № 11. — P.231−243.
- Lang K., Lang P. Bauer C., Duranton C., Wieder Т., Huber S., Lang F. Mechanisms of suicidal erythrocyte death. // Cell. Physiol. Biochem. 2005. — V. l 5. — № 5. — P. 195−202.
- Lang P., Kaiser S., Myssina S., Wieder Т., Lang F., Huber S. Role of Ca2±activated K+ channels in human erythrocyte apoptosis. // Am. J. Physiol. Cell. Physiol. — 2003. -V.285. — P.1553−1560.
- Lang P., Kempe D., Myssina S., Tanneur V., Birka C., Laufer S., Lang F., Wieder Т., Huber S. PGE (2) in the regulation of programmed erythrocyte death. // Cell. Death. Differ. -2005. V.12. — № 5. — P.415−428.
- Lee M J., Clement J.G. Effects of soman poisoning on hematology and coagulation parameters and serum biochemistry in rabbits. // Military medicine. 1990. — V. l55. — № 6. — P.244−249.
- Levin E.G., Marzec U., Anderson J., Harker L.A. Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. // J. Clin. Invest. -1984. V.74. — № 6. — P. 1988−1995.
- Li В., Sedlacek M., Manoharan I. Butyrylcholinesterase, paraoxonase and albumin esterase, but not carboxylesterase, are present in human plasma. // Biochem. Pharmacol. — 2005. V.70. — № 11. — P.1673−1684.
- Lincoln T.M., Cornwell T.L. Intracellular cyclic GMP receptor protein. // FASEB J.- 1993. — V.7. P.328−338.
- Lip G.Y.H., Blann A. Review von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? // Cardiovascular Research. 1997. — V.34. — P.255−265.
- Liu L., Choi H., Bernardo A., Bergeron A.L., Nolasco L., Ruan C., Moake J.L., Dong J.-F. Platelet-derived VWF-cleaving metalloprotease ADAMTS-13. // J. Thromb. Haemost. 2005. — V.3. — P.2536−2544.
- Look A.T., Ashmun R.A., Shapiro L.H., Peiper S.C. Human myeloid plasma membrane glycoprotein CD13 (gpl50) is identical to aminopeptidase N. // J. Clin. Invest. -1989. V.83. — № 4. — P.1299−1307.
- Lorenzet R., Sobel J.H., Bini A., Witte L.D. Low molecular weight fibrinogen degradation products stimulate the release of growth factors from endothelial cells. // Thromb. Haemost. 1992. — V.68. — P.357−363.
- Lotti M. Organophosphate-induced delayed polyneuropathy in humans: perspectives for biomonitoring. // Trends. Pharmacol. Sci. 1987. — V.8. — P. 175−176.
- Lotti M. The pathogenesis of organophosphate neuropathy. // Crit. Rev. Toxicol. -1992. — V.21. — P.465−487.
- Lotti M. Cholinesterase inhibition: complexities in interpretation. // Clin. Chem. -1995. — V.41. P. 1814−1818.
- Lotti M. Organophosphorus compounds. // In: Experimental and Clinical Neurotoxicology. (Ed. by Spencer P. S, Schaumburg H. H, Ludolph A.C.). Oxford: Oxford University Press, 2000. — P.898−925.
- Lotti M. Clinical toxicology of anticholinesterase agents in humans. // In: Handbook of Pesticide Toxicology. San Diego: Academic Press, 2001. — P. 1043−1085.
- Low P.A. Endoneurial fluid pressure and microenvironment of nerv. // In: Peripheral Neuropathy (Ed. by Dyck P.J.) WB Saunders, Philadelphia, 1984. — P.599−617.
- Lux S.E., John K.M., Kopito R.R., Lodish H.F. Cloning and characterization of band 3, the human erythrocyte anion-exchange protein (AE1). // Proc. Natl. Acad. Sci. USA. -1989. V.86. — № 23. — P.9089−9093.
- Lwaleed B.A., Bass P. S. Tissue factor pathway inhibitor: Structure, biology and involvement in disease. // J. Pathol. 2006. — V.208. — № 3. — P, 327−339.
- Lyberg T. Clinical Significance of Increased Thromboplastin Activity on the Monocyte Surface A Brief Review. // Haemostasis. — 1984. — V.14. — P.393−399.
- MacFarlane R.G. An enzyme cascade in the blood clotting mechanism and its function as a biochemical amplifier. // Nature. 1964. — V.202. — P.498−499.
- Mack A., Robitzki A. The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5'butyrylcholinesterase-DNA study. // Prog. Neurobiol.2000. V.60. — № 6. — P.607−628.
- Mahaut-Smith M.P., Sage S.O., Rink T.J. Rapid ADP-evoked currents in human platelets recorded with the nystatin permeabilized patch technique. // J. Biol. Chem. — 1992.1. V.267. — P.3060−3065.
- Mahaut-Smith M.P., Ennion S.J., Rolf M.G., Evans R.J. ADP is not an agonist at P2X (1) receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets. // Br. J. Pharmacol. 2000. — V. 131. — № 1. — P. 108−114.
- Malik R.A. Masson E.A., Sharma A.K., Lye R.H., Ah-See A.K. et al. Hypoxic neuropathy: relevance to human diabetic neuropathy. // Diabetologia. — 1990. — V.33. — № 5.1. P.311−318.
- Mannucci P.M., Canciani M.T., Forza I., Lussana F., Lattuada A., Rossi E. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. // Blood.2001. V.98. — P.2730−2735.
- Maroni M., Bleecker M.L. Neuropathy target esterase in humanlymphocytes and platelets. // J. Appl. Toxicol. 1986. — V.6. — P. 1−7.
- Maroni M., Colosio C., Ferioli A., Fait A. Biological monitoring of pesticide exposure: a review. // Toxicology. 2000. — № 143. — P.5−118.
- McMullin M.F., Percy M.J. Erythropoietin receptor and hematological disease. // Am. J. Hematol. 1999. — V.60. — № 1. — P.55−60.
- Means G. E., Bender M.L. Acetylation of human serum albumin by p-nitrophenyl acetate. // Biochemistry. 1975. — V.14. — P.4989−4994.
- Medda S., Swank R.T. Egasyn, a protein which determines the subcellular distribution of beta-glucuronidase, has esterase activity. // J. Biol. Chem. — 1985. — V.260. -№ 29.-P. 15 802−15 808.
- Michiels C. Endothelial cell functions. // J. Cell. Physiol. 2003. — V.196. — № 3. -P.430−443.
- Mina-Osorio P., Winnicka В., O’Conor C» Grant C.L., Vogel L.K., Rodriguez-Pinto
- D., Holmes K.V., Ortega E., Shapiro L.H. CD13 is a novel mediator of monocytic/endothelial cell adhesion. // J. Leukoc. Biol. 2008. — V.84. — № 2. — P.448−459.
- Mindukshev I.V., Krivoshlyk V.V., Ermolaeva E.E., Dobrylko I.A., Senchenkov
- E.V., Goncharov N.V., Jenkins R.O., Krivchenko A.I. Necrotic and apoptotic volume changes of red blood cells investigated by low-angle light scattering technique. // Spectroscopy Int. J. 2007. — V.21. — № 2. — P. 105−120.
- Moore D. Low dose exposure to nerve agent. Long term health effects of nerve agent exposure // Rep. 1 symp. chem. and biological medical treatment. — Cairo, 1997. — Suppl. — P.34.
- Morris M.B., Lux S.E. Characterization of the binary interaction between human erythrocyte protein 4.1 and actin. // Eur. J. Biochem. 1995. — V.231. — № 3. — P.644−650.
- Murachi T. A general reaction of diisopropylphosphorofluoridate with proteins without direct effect on enzymatic activities. // Biochim. Biophys. Acta. 1963. — V.71. -P.239−241.
- Myers R.R. Powell H.C., Shapiro H.M., Costello M.L., Lampert P.W. Changes in endoneurial fluid pressure, permeability, and peripheral nerve ultrastructure in experimental lead neuropathy. //Ann. Neurol. 1980. — V.8. -P.392−401.
- Nachmias V.T. Cytoskeleton of human platelets at rest and after spreading. // J.Cell. Biol. 1980. — V.86. — P.795−802.
- Namba Т., Nolte C.T., Jackrel J., Grob D. Poisoning due to organophosphate insecticides. Acute and chronic manifestations. // Am. J. Med. 1971. — V.50. — 4. — P.475−492.
- Norenberg M.D. A Hypothesis of Osmotic Endothelial Injury. A Pathogenetic Mechanism in Central Pontine Myelinolysis. // Arch. Neurol. 1983. — V.40. — P.66−69.
- Nossel H.L., Yudelman I., Caned R.E., Bumz V.P., Spanondis K., Wimm G.D., Qumeas G.D. Measurement of Fibrinopeptide A in Human Blood. // J. Clin. Invest. 1974. — V.54.-P.43−53.
- O’Neill J.J. Non-cholinesterase effects of anticholinesterases. // Fundam. Appl. Toxicol. 1981.-V.l.-P. 154−160.
- Odman S., Levitan H., Robinson P.J. Peripheral nerve as an osmometer: role of endoneural capillaries in frog sciatic nerve. // Am. J. Physiol. 1987. — V.25. — P.335−341.
- Olsson Y. Vascular permeability in the peripheral nervous system. // In: Peripheral Neuropathy (Ed. By Dyck P.J.) WB Saunders, Philadelphia, 1984. — P. 579−597.
- Orlowski M., Sessa G., Green J.P. Gamma-glutamyl transpeptidase in brain capillaries: possible site of a blood-brain barrier for amino acids. // Science. 1974. -V.l84. -№ 132. — P.66−68.
- Owen W.G., Esmon С.Т. Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. // J. Biol. Chem. 1981. — V.256. — P.5532−5535.
- Padilla S, Wilson V. A, Bushnell P.J. Studies on the correlation between blood cholinesterase inhibition and target tissue inhibition in pesticide-treated rats. // Toxicology. 1994.-V.92-P. 11−25.
- Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. //Nature. 1987. — V.327. — № 6122. — P.524−526.
- Palmieri F.E., Bausback H.H., Ward P.E. Metabolism of vasoactive peptides by vascular endothelium and smooth muscle aminopeptidase M. // Biochem. Pharmacol. -1989. V.38. -№ 1. — P.173−180.
- Parnavelas J.G., Kelly W., Burnstock G. Ultrastructural localization of choline acetyltransferase in vascular endothelial cells in rat brain. // Nature. 1985. — V.316. -№ 6030. — P.724−725.
- Peeples E.S., Schopfer L.M., Duysen E.G., Spaulding R., Voelker Т., Thompson C.M., Lockridge O. Albumin, a new biomarker of organophosphorus toxicant exposure, identified by mass spectrometry. // Toxicol. Sci. 2005. — V.83. — № 2. — P.303−312.
- Peerschke E.I., Ghebrehiwet B. Platelet interactions with Clq in whole blood and in the presence of immune complexes or aggregated IgG. // Clin. Immunol. Immunopathol. -1992. V.63. — № 1. — P.45−50.
- Peerschke E.I., Ghebrehiwet B. Clq augments platelet activation in response to aggregated Ig. // J. Immunol. 1997. -V. 159. -№ 11.- P.5594−5598.
- Peerschke E.I., Ghebrehiwet B. Platelet receptors for the complement component Clq: implications for hemostasis and thrombosis. // Immunobiology. 1998. — V.199. -№ 2. — P.239−249.
- Phan S.H., Gannon D.E., Varani J., Ryan U.S., Ward P.A. Xanthine oxidase activity in rat pulmonary artery endothelial cells and its alteration by activated neutrophils. // Am. J. Pathol. 1989. — V. 134. — № 6. — P. 1201 -1211.
- Pisano J.J., Finlayson J.S., Peyton M.P. Cross-link in fibrin polymerized by factor 13: epsilon-(gamma-glutamyl)lysine. // Science. 1968. — V.160. — № 830. -P.892−893.
- Pohlman Т.Н., Harlan J.M. Adaptive responses of the endothelium to stress. // J. Surg. Res. 2000. — V.89. — № 1. — P.85−119.
- Pope C.N. Organophosphorous pesticides: Do they all have the same mechanism of toxicity? Hi. Toxicol. Environ. Health. В Crit. Rev. 1999. — V.2. — P. 161−181.
- Pope C., Karanth S., Liu J. Pharmacology and toxicology of cholinesterase inhibitors: uses and misuses of a common mechanism of action. // Environ. Toxicol. Pharmacol. -2005. -V. 19. № 3. — P.433−446.
- Poulsen E., Aldridge W.N. Studies on esterases in the chicken central nervous system.//Biochem. J. 1964. — V.90.-№ 3. — P. 182−189.
- Prall Y.G., Gambhir K.K., Ampy F.R. Acetylcholinesterase: an enzymatic marker of human red blood cell aging. // Life Sci. 1998. — V.63. -№ 3. — P. 177−184.
- Quistad G.B., Klintenberg R., Casida J.E. Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicants. // Toxicol. Sci. 2005. — V.86. — № 2. — P.291−299.
- Ray D.E., Richards P.G. The potential for toxic effects of chronic low-dose exposure to organophosphates. //Toxicol. Lett.-2001.-V.120. -P.343−351.
- Ray D.E. Organophosphorous esters: An evaluation of chronic neurotoxic effects. // Leicester, 1998. -p.62.
- Richards P.G., Johnson M.K., Ray D.E. Identification of acylpeptide hydrolase as a sensitive site for reaction with organophosphorus compounds and a potential target for cognitive enhancing drugs. // Mol. Pharmacol. 2000. — V.58. — P.577−583.
- Rink T.J., Smith S.W., Tsien R.Y. Cytoplasmic free Ca2+ in human platelets: Ca2+ thresholds and Ca-independent activation for shape change and secretion. // FEBS Lett. -1982. V.148. -P.21−26.
- Roeschlau P., Bernt P., Gruber W. Enzymatic determination of total cholesterol in serum.//J. Clin. Chem. Clin. Biochem. 1974.-V. 12-P.457−464.
- Ruttmann E., Brant L.J., Concin H., Diem G., Rapp K., Ulmer H. Gamma-Glutamyltransferase as a Risk Factor for Cardiovascular Disease Mortality. // Circulation. -2005. V. l 12. — P.2130−2137.
- Saida K., Kawakami H., Ohta M., Iwamura K. Coagulation and vascular abnormalities in Crow-Fukase syndrome. // Muscle Nerve. 1997. — V.20. — № 4. — P.486−492.
- Santos S.C., Vala I., Miguel C. Expression and subcellular localization of a novel nuclear acetylcholinesterase protein. // J. Biol. Chem. 2007. — V.282. — № 35. — P.25 597−25 603.
- Scrutton M.C. The platelet as Ca2±driven cell: Mechanisms which may modulate Ca2±driven responses. Mechanisms of platelet activation and control. // New York: Plenum Press, 1993.-P.1−15.
- Sedgwick E. M, Sananayake N. Pathophysiology of the intermediate syndrome of organophosphorus poisoning. // J Neurol. Neurosurg. Psychiatry 1997. — V.62 — P.201−202.
- Seigneur M., Dufourcq P., Conri C. Plasma thrombomodulin: new approach of endothelium damage. // Int. Angiol. 1993. — V.12. — P.355−359.
- Senanayke N., Karalliedde L. Neurotoxic effects of organophosphorus insecticides: an intermediate syndrome. //N. Engl. J. Med. 1987. — V.316. — P.761−763.
- Shimada K., Ozawa T. Release of heparan sulfate proteo glycans from cultured aortic endothelial cells by thrombin. // Thromb. Res. 1985. — V.39. — P.387−397.
- Siess W. Molecular mechanisms of platelet activation. // Physiol. Rev. — 1989. -V.69. — № 1.-P.58−178.
- Silveira C.L., Eldefrawi A.T., Eldefrawi M.E. Putative M2 muscarinic receptors of rat heart have high affinity for organophosphorus anticholinesterases. // Toxicol. Appl. Pharmacol. 1990. — V. l 03. — P.474−481.
- Simeon-Rudolf V., Reiner E., Evans R.T. Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by 4,4'-bipyridine and by a coumarin derivative. // Chem.-Biol. Interact. 1999. — V. l 19−120. — P.165−171.
- Small D.H., Michaelson S., Sberna G. Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer’s disease. //Neurochem. Int. 1996. — V.28. — № 5−6. — P.453−483.
- Snawder J.E., Chambers J.E. Osteolattyrogenic effects of malathion in Xenopus embryos. // Toxicol. Appl. Pharmacol. -1993. V.212. -P.210−216.
- Spater H.W., Poruchynsky M.S., Quintana N., Inoue M., Novikoff A.B. Immunocytochemical localization of gamma-glutamyltransferase in rat kidney with protein A-horseradish peroxidase. // Proc. Nat. Acad. Sci. USA. 1982. — V.79. -№ 11.- P.3547−3550.
- Sporn L.A., Marder V.J., Wagner D.D. Inducible secretion of large, biologically potent vWf multimers. // Cell. 1986. -V.46. — P. l85−190.
- Spycher M.O., Nydegger U.E. Participation of the Blood Platelet in Immune Reactions Due to Platelet-Complement Interaction. // Infusionsther. Transfusionsmed. — 1995. V.22. — N.l. — P.36−43.
- Suidan H.S., Stone S., Hemmings В., Monard D. Thrombin causes neurite retraction in neuronal cells through activation of cell surface receptors. // Neuron. 1992. — V.8. — P.363−375.
- Suidan H.S., Nobes C.D., Hall A., Monard D. Astrocyte spreading in response to thrombin and lysophosphatidic acid is dependent on the Rho GTPase. // Glia. 1997. -V.21. —P.244−252.
- Szasz G. A Kinetic Photometric Method for Serum y-GIutamyl Transpeptidase. // Clinical Chemistry. 1969. — V. 15. — P. 124−136.
- Talke H., Schubert G.E. Enzymatic urea determination in the blood and serum in the Warburg optical test. Article in German. // Klin. Wochenschr. 1965. — V.43. — № 1. -P.174−175.
- Tervo T. Histochemical demonstration of cholinesterase activity in the cornea of the rat and the effect of various denervations on the corneal nerves. // Histochemistry. — 1976. -V.47. — № 2. P. 133−143.
- Tildon J.T., Ogilvie J.W. The Esterase Activity of Bovine Mercaptalbumin. The reaction of the protein with p-nitrophenyl acetate. // J. Biol. Chem. 1972. — V.247. -P.1265−1271.
- Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. // Ann. Clin. Biochem. 1969. — V.6. — P.24−25.
- Tunek A., Hjertberg E., Mogensen J.V. Interactions of bambuterol with human serum cholinesterase of the genotypes EuEu (normal), EaEa (atypical) and EuEa. // Biochem. Pharmacol. 1991. — V.41. — 3. — P.345−348.
- Uchiyama Т., Matsumoto M., Kobayashi N. Studies on the pathogenesis of coagulopathy in patients with arterial thromboembolism and malignancy. // Thromb. Res. -1990. V.59. — P.955−965.
- Uemura M., Tatsumi K., Matsumoto M., Fujimoto M., Matsuyama Т., Ishikawa M., Iwamoto Т., Mori Т., Wanaka A., Fukui H., Fujimura Y. Localization of ADAMTS13 to the stellate cells of human liver. // Blood. 2005. — V. 106. — P.922−924. /
- Van Hinsbergh V.W.M., Sprengers E.D., Kooistra T. Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. // Thromb. Haemost. 1987. — V.57. — № 2. — P. 148−153.
- Van Rhijn I., Van den Berg L.H., Bosboom W.M.J., Otten H.G. and Logtenberg T. Expression of accessory molecules for T-cell activation in peripheral nerve of patients with CIDP and vasculitic neuropathy // Brain. 2000. — V.123 — № 10. — P.2020−2029.
- Vane J.R., Anggard E.E., Batting R.M. Regulatory functions of the vascular endotnelium. //New Engl. J. Med. 1990. — V.323. — P.27−36.
- Von Kaulla K., Holmes J.H. Changes following anticholinesterase exposures. Blood coagulation studies. // Arch. Environ. Health. 1961. — V.2. — P. 168−177.
- Wada H., Ksneko Т., Ohiwa M. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura. // Am. J. Hematol. 1993. — V.44. — P.101−105.
- Wagner D.D. Cell biology of von Willebrand factor. // Annu. Rev. Cell. Biol. -1990.-V.6.-P.217−246.
- Wahlefeld A.W. Methods of enzymatic analysis. // Academic Press, 1974.
- Walker C.H. The classification of esterases which hydrolyse organophosphates: recent developments. // Chem. Biol. Interact. 1993. — V.87. — № 1−3. — P. 17−24.
- Walsh P.N. Factor XI. // In: Hemostasis and thrombosis: basic principles and clinical practice (Ed. by Colman R.W., Hirsh J., Marder V.J.), 4th ed., Ch.ll. Philadelphia: Lippincott, Williams and Wilkins, 2001. P. l 91−202.
- Wang L., Ostberg O., Wihlborg A., Brogren H., Jem S., Erlinge D. Quantification of ADP and ATP receptor expression in human platelets. // J. Thromb. Haemost. 2003. -V.l. — № 2. — P.330−336.
- Weiss P., Wang H., Taylor C., Edds M.J.Jr. Proximo-distal fluid convection in the endoneurial spaces of peripheral nerves, demonstated by colored radioactive (isotope) tracers. // Am. J. Physiol. 1945. — V.143. — P.521 -540.
- Weksler B.B., Ley C.W., Jaffe E.A. Stimulation of Endothelial Cell Prostacyclin Production by Thrombin, Trypsin and the Ionophore A 23 187. // J. Clin. Invest. 1978. -V.62. — P.923−930.
- Winrow C.J., Hemming M.L., Allen D.M., Quistad G.B., Casida J.E., Barlow C. Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. //Nat. Genet. 2003. — V.33. -№ 4. — P.477−485.
- Worek F., Koller M., Thiermann H., Szinicz L. Diagnostic aspects of organophosphate poisoning. // Toxicology. 2005. — V.214. — P.182−189.
- Wright I.S. The nomenclature of blood clotting factors. // Can. Med. Assoc. J. -1962. V.86. — № 8. — P.373−374.
- Yachie A., Niida Y., Wada Т., Igarashi N., Kaneda H., Toma Т., Ohta K., Kasahara Y., Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. // J. Clin. Invest. 1999. — V. 103. — № 1. — P. 129−135.
- Yuan Y., Bergmann M., Gerfelmeyer G., Kuchelmeister K. Giant axonal neuropathy. A case report. Article in German.//Pathologe. 1996. — V.17.-№ 3. — P.213−218.
- Zeiher A.M., Drexler H., Saurbier В., Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. // J. Clin. Invest. 1993. — V.92. — № 2. — P.652−662.
- Zhang S.C., Schultz D., Ryan U. Receptor-mediated binding of Clq on pulmonary endothelial cells. // Tissue and Cell. 1986. — V.18. -№ 1. — P. 13−18.
- Zheng X.L., Sadler J.E. Pathogenesis of Thrombotic Microangiopathies. // Annu. Rev. Pathol. 2008. — V.3. — P.249−277.
- Zhou J.F., Xu G.B., Fang W.J. Relationship between acute organophosphorus pesticide poisoning and damages induced by free radicals. // Biomed. Environ. Sci. 2002.1. V.15. — № 2. -P.177−186.
- Ziemen M. Platelet function and coagulation disorders in organophosphate intoxication. Article in German. // Klin. Wochenschr. 1984a. — V.62. — № 17. — P.814−820.
- Ziemen M. Thrombocyte function and plasma coagulation following poisoning with organophosphates. Article in German. // Klin. Wochenschr. 1984b. — V.62. — № 17. -P.814−820.